The optimal approach to prevent stroke and systemic embolism in patients with advanced
chronic kidney disease (CKD) and atrial fibrillation remains unresolved. We conducted a …

Background: Oral anticoagulants (OAC) reduce the risk of stroke but impose the risk of
bleeding in patients with atrial fibrillation (AF). In the setting of advanced chronic kidney …

Background The net benefit of oral anticoagulation (OAC) with vitamin K antagonists or
direct oral anticoagulants in patients with advanced chronic kidney disease and atrial …

Compared to patients with normal renal function, the prevalence of atrial fibrillation (AF) in
chronic kidney disease (CKD) is increased, as is consequently the stroke prevalence in …

Atrial fibrillation (AF) and chronic kidney disease (CKD) are increasingly prevalent in the
general population and share common risk factors such as older age, hypertension and …

Introduction: Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are
individually associated with a higher incidence of stroke as compared with the general …

Chronic kidney disease affects more than 3 million Canadians and is highly associated with
cardiovascular diseases that require anticoagulation, such as atrial fibrillation and venous …

Novel oral anticoagulants in chronic kidney disease: ready f... : Current Opinion in Nephrology
and Hypertension Novel oral anticoagulants in chronic kidney disease: ready for prime time …

Background: Chronic kidney disease (CKD) is associated with a high prevalence of atrial
fibrillation (AF), but in this population the risk/benefit ratio of anticoagulant therapy with …

Atrial fibrillation (AF) represents the most common arrhythmia in patients with chronic kidney
disease (CKD). As in the general population, in CKD patients AF is associated with an …